Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

Stanley, Daphne A, Honko, Anna N, Asiedu, Clement, Trefry, John C, Lau-Kilby, Annie W, Johnson, Joshua C, Hensley, Lisa, Ammendola, Virginia, Abbate, Adele, Grazioli, Fabiana, Foulds, Kathryn E, Cheng, Cheng, Wang, Lingshu, Donaldson, Mitzi M, Colloca, Stefano, Folgori, Antonella, Roederer, Mario, Nabel, Gary J, Mascola, John, Nicosia, Alfredo, Cortese, Riccardo, Koup, Richard A, Sullivan, Nancy J·2014·Nature Medicine

DOI 10.1038/nm.3702

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nm.3702

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
New Vaccine Technologies to Combat Outbreak Situations
Rauch, S., Jasny, E., Schmidt, K. E., & Petsch, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01963 · Cited by 579
A monovalent chimpanzee adenovirus Ebola vaccine boosted with MVA
Ewer, K., Rampling, T., Venkatraman, N., Bowyer, G., Wright, D., Lambe, T., Imoukhuede, E. B., Payne, R., Fehling, S. K., Strecker, T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1411627 · Cited by 348
Self-citation
What policy makers need to know about COVID-19 protective immunity
Altmann, D. M., Douek, D. C., & Boyton, R. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30985-5 · Cited by 223
Marburg virus disease: a summary for clinicians
Kortepeter, M. G., Dierberg, K., Shenoy, E. S., & Cieslak, T. J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.042 · Cited by 160
Adenovirus vector-based vaccine for infectious diseases
Sakurai, F., Tachibana, M., & Mizuguchi, H. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2021.100432 · Cited by 148
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: an open phase I/II trial in healthy adults in Russia
Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Dzharullaeva, A. S., Tukhvatulina, N. M., Shcheblyakov, D. V., Shmarov, M. M., Tokarskaya, E. A., Simakova, Y. V., Egorova, D. A., et al. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1238535 · Cited by 132
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
Hamer, M. J., Houser, K. V., Hofstetter, A. R., Ortega-Villa, A. M., Lee, C., Preston, A., Augustine, B., Andrews, C., Yamshchikov, G. V., Hickman, S., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02400-x · Cited by 69
Self-citation
What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans?: The Importance of Bridging Studies and Species-Independent Correlates of Protection
Golding, H., Khurana, S., & Zaitseva, M. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028902 · Cited by 67
Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models
Brunetti-Pierri, N., & Ng, P. (2017) · Virus Genes · doi:10.1007/s11262-017-1471-x · Cited by 32

Authors: Stanley, D. A., Honko, A. N., Asiedu, C., Trefry, J. C., Lau-Kilby, A. W., Johnson, J. C., Hensley, L., Ammendola, V., Abbate, A., Grazioli, F., Foulds, K. E., Cheng, C., Wang, L., Donaldson, M. M., Colloca, S., Folgori, A., Roederer, M., Nabel, G. J., Mascola, J., Nicosia, A., Cortese, R., Koup, R. A., & Sullivan, N. J.
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 2014-09-07
Volume: 20
Issue: 10
Pages: 1126-1129
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/nm.3702
OpenAlex: W2076340825
Cited by: 350
References: 0
FWCI: 38.94
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review